Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PENNTUSS

CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX

Standard Dose
EQ 4MG MALEATE/5ML;EQ 10MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PENNTUSS is listed in Drugs@FDA under application 018928 (NDA).

Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 4MG MALEATE/5ML;EQ 10MG BASE/5ML Sponsor FISONS Submission history Latest submission status date: 1987-05-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview PENNTUSS is listed in Drugs@FDA under application 018928 (NDA). Marketing status: Discontinued Active ingredient CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 4MG MALEATE/5ML;EQ 10MG BASE/5ML Sponsor FISONS Submission history Latest submission status date: 1987-05-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.